Determination of the Infective Dose of Staphylococcus aureus (ATCC 29213) and Pseudomonas aeruginosa (ATCC 27853) When Injected Intraperitoneally in Sprague Dawley Rats
Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 14, Issue 1
Abstract
Objective: To determine the infective dose of Staphylococcus aureus (ATCC 29213) and Pseudomonas aeruginosa (ATCC 27853) in Sprague Dawley rats, when the inoculum is injected via the intraperitoneal route. Design and Methods: In interest of animal welfare and to reduce the number of animals used, we utilized the “up-down procedure” for dose determination of Pseudomonas aeruginosa and Staphylococcus aureus. Animals were grouped in fours, injected IP with inoculums of known concentration of a single organism and observed for 10 days. Clinical signs such as lethargy, increased respiration, porphyrin staining was recorded. Gross necropsy was performed ten (10) days post infection. Only one infective dose was done at a time and depending on the outcome, the size of inoculum was adjusted for the next step in the experimental infectious process. Results: Doses of inoculum was carefully titrated and the highest tolerable dose for each organism was determined. These doses allowed for survival of the animals and gave clinical signs, which mimicked the scenario in a human population. Symptoms of infection included lethargy, ruffled fur, porphyrin staining, dehydration and hunched back. At necropsy at 10 days post infection, common indicators of infection observed were ascites, abscesses on the intestinal wall, kidneys, liver and spleen. There were also fibrin tags, rounded livers, enlarged spleen and increased pericardial effusion was prominent in the S. aureus infected group. Conclusions: The infective doses were determined based on clinical signs, survival and post mortem changes. The doses determined for Staphylococcus aureus (ATCC 29213) was 1.75 X 1010 cfu/ml and Pseudomonas aeruginosa (ATCC 27853) was 3.0 X 108cfu/ml. These doses would be useful in infective animal studies to determine the efficacy of antimicrobial agents.
Authors and Affiliations
Satish Jankie, Johnson Jenelle, Rod Suepaul, Lexley Pinto Pereira, Patrick Akpaka, Amusa Sarafadeen Adebayo, Gopalkrishna Pillai
Keywords
Related Articles
- EP ID EP342087
- DOI 10.9734/BJPR/2016/29932
- Views 84
- Downloads 0
The Role of Losartan and Oral Magnesium Sulfate in Cisplatin Induced Nephrotoxicity in Female Rats
Hypomagnesemia is one of the nephrotoxicity signs. In addition, renin-angiotensin system may be involved in pathophysiology of kidney diseases. Therefore, the present study was designed to investigate the possible role o...
Evaluation of C. cassia Effectiveness in Behavioral Modulation of Haloperidol Induced Parkinson’s Disease (Mice Model)
Aims: This study was undertaken to evaluate the effectiveness of behavioral modulation of C. cassia extract against Haloperidol induced Parkinson’s disease (PD) in albino mice. Study Design: The study used...
Phytochemical and Biological Evaluation of R. hastatus and R. himalyica (Polygonaceae) from Galiyat Pakistan
The medicinal plants have been known for their wide variety of applications for centuries. R. hastatus and R. himalyica are such medicinal plants which have been used in Ayurveda for their excell...
RP-HPLC and HPTLC Methods for Simultaneous Estimation of Metformin Hydrochloride and Vildagliptin from Bulk and Marketed Formulation: Development and Validation
The reversed-phase high performance liquid chromatography (RP-HPLC) and high performance thin layer chromatography (HPTLC) methods for simultaneous estimation of Metfomin Hydrochloride (MET) and Vildagliptin (VLD) in bul...
Antimalarial Activity of Root Bark Extract and Fractions of Callichilia stenopetala Stapf (Apocynaceae) against Plasmodium berghei in Mice
Introduction: Malaria is a life threatening disease caused by infection of red cells by Plasmodium parasites and is very prevalent due to emergence of resistance to the parasites. The plant Callichilia stenopetala Stapf...